MK0476 [montelukast] phase III double-blind comparative study - allergic rhinitis.

Trial Profile

MK0476 [montelukast] phase III double-blind comparative study - allergic rhinitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Montelukast (Primary) ; Pranlukast
  • Indications Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 17 Sep 2008 Actual patient number (1375) added as reported by ClinicalTrials.gov.
    • 17 Sep 2008 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
    • 17 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top